Kilder

Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, Fruh A, Edvardsen T, Kongsgard E, Leren TP, et al. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2010;12:417-423. doi: 10.1093/europace/eup448

Leren IS, Haugaa KH, Edvardsen T, Anfinsen OG, Kongsgard E, Berge KE, Leren TP, Amlie JP. Catecholaminergic polymorphic ventricular tachycardia. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2010;130:139-142. doi: 10.4045/tidsskr.09.0529

Leren IS, Saberniak J, Majid E, Haland TF, Edvardsen T, Haugaa KH. Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with beta1-selective beta-blockers in patients with catecholaminergic polymorphic ventricular tachycardia. Heart rhythm. 2016;13:433-440. doi: 10.1016/j.hrthm.2015.09.029

Pflaumer A, Davis AM. Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia. Heart Lung Circ. 2012;21:96-100. doi: 10.1016/j.hlc.2011.10.008

Watanabe H, Minamino T. Genetics of Brugada syndrome. J Hum Genet, 2016. 61(1): 57-60. 3.

Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation, 2002. 106(19): 2514-2519. 2.

Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J, 2022. 43(40): 3997-4126.